TriSalus Life Sciences, Inc. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
TriSalus Life Sciences, Inc. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does TriSalus Life Sciences, Inc. do? Business model and key facts
Get the full picture of TriSalus Life Sciences, Inc.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Medical - Devices
Employees (FY): 102
TriSalus Life Sciences, Inc. is an immunotherapy firm dedicated to the research, development, and market introduction of treatments that leverage the body's immune system, primarily targeting liver and pancreatic cancers. Its product portfolio includes the TriNav Infusion System for liver tumors and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors, alongside SD-101, an investigational immunotherapeutic in development for several cancer indications. The company is headquartered in Westminster, Colorado.
Stocks related to TriSalus Life Sciences, Inc.
Selected based on industry alignment and relative market positioning.
Events and news impacting TriSalus Life Sciences, Inc. stock
Earnings, coporate decisions and industry developments that can affect the share price.
TriSalus Life Sciences, Inc. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
